Markham Based Medical Diagnostics Company GeneNews to Provide Prostate Health Index (PHI) Testing Services to MD Anderson Cancer Center in Texas

Markham, ON — Sept. 3, 2015 (GLOBE NEWSWIRE) — GeneNews Limited (TSX:GEN) (“GeneNews” or the “Company”) today announced that its Innovative Diagnostic Laboratory (“IDL”) joint-venture has signed an agreement with The University of Texas MD Anderson Cancer Center (“MD Anderson”) pursuant to which IDL will provide MD Anderson with Prostate Health Index (“PHI”) testing services.

“There is significant interest in IDL’s early cancer diagnostic tests from hospital groups and large physician practice groups,” said Mr. Howard-Tripp. “IDL is actively pursuing these opportunities and the signing of MD Anderson to the PHI tests now complements arrangements we have with other institutions.

Full Article Here: money.cnn.com